Morpholine → HCID 59174903, compound
Reaction equation
[F:1][C:2]1[CH:3]=[C:4]([CH:8]=[CH:9][C:10]=1[C:11]1[S:12][C:13]2[C:18]([N:19]=1)=[CH:17][CH:16]=[C:15]([C:20]1([C:23]3[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=3)[CH2:22][CH2:21]1)[N:14]=2)[C:5]([OH:7])=O.[NH:29]1[CH2:34][CH2:33][O:32][CH2:31][CH2:30]1>>[F:1][C:2]1[CH:3]=[C:4]([C:5]([N:29]2[CH2:34][CH2:33][O:32][CH2:31][CH2:30]2)=[O:7])[CH:8]=[CH:9][C:10]=1[C:11]1[S:12][C:13]2[C:18]([N:19]=1)=[CH:17][CH:16]=[C:15]([C:20]1([C:23]3[CH:24]=[CH:25][CH:26]=[CH:27][CH:28]=3)[CH2:22][CH2:21]1)[N:14]=2Participants
3
Procedure
The title compound was synthesized using the described in Example 105 above using 3-fluoro-4-(5-(1-phenylcyclopropyl)thiazolo[5,4-b]pyridin-2-yl)benzoic acid (101 mg, 0.259 mmol) and morpholine. MS (ESI) m/z: Calculated: 459.1; Observed: 460.1 (M++1).
Sources & evidence
- ORD record
- ord-0a0804dace5d4839846c8954259cd5b9
- Source dataset
- uspto-grants-2010_11
- Patent number
- US07842685B2
Reaction notes
Loading…